Subependymal giant cell astrocytoma epidemiology and demographics
Subependymal giant cell astrocytoma Microchapters |
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Subependymal giant cell astrocytoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma epidemiology and demographics |
FDA on Subependymal giant cell astrocytoma epidemiology and demographics |
CDC on Subependymal giant cell astrocytoma epidemiology and demographics |
Subependymal giant cell astrocytoma epidemiology and demographics in the news |
Blogs on Subependymal giant cell astrocytoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Prevalence
- There have been 110 reported cases of subependymal giant cell astrocytomas in the literature.[1]
- The prevalence of subependymal giant cell astrocytoma is estimated to be 110 cases in total.[1]
Incidence
- The incidence of subependymal giant cell astrocytoma is approximately 2.5 per 100,000 individuals in the United States.[2]
Age
Gender
Race
Reference
- ↑ 1.0 1.1 Nabbout, R; Santos, M; Rolland, Y; Delalande, O; Dulac, O; Chiron, C (1999). "Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis". Journal of Neurology, Neurosurgery & Psychiatry. 66 (3): 370–375. doi:10.1136/jnnp.66.3.370. ISSN 0022-3050.
- ↑ Roth, Jonathan; Roach, E. Steve; Bartels, Ute; Jóźwiak, Sergiusz; Koenig, Mary Kay; Weiner, Howard L.; Franz, David N.; Wang, Henry Z. (2013). "Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012". Pediatric Neurology. 49 (6): 439–444. doi:10.1016/j.pediatrneurol.2013.08.017. ISSN 0887-8994.